These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7370086)

  • 1. Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome.
    Kashyap ML; Srivastava LS; Hynd BA; Brady D; Perisutti G; Glueck CJ; Gartside PS
    Atherosclerosis; 1980 Jan; 35(1):29-40. PubMed ID: 7370086
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamics of C-apolipoproteins in the enzymatic interconversions of plasma lipoproteins.
    Kinnunen PK; Vainio P; Virtanen JA
    Ric Clin Lab; 1982; 12(1):41-9. PubMed ID: 7046022
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein C-II and lipoprotein lipase activity.
    Catapano AL
    Ric Clin Lab; 1982; 12(1):35-40. PubMed ID: 7046021
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro catabolism of human very low density lipoproteins: fate of apoproteins B and C.
    Catapano AL; Capurso A; Kinnunen PK
    Artery; 1981; 9(2):87-95. PubMed ID: 7295047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue lipoprotein lipase activity and its action in lipoprotein metabolism.
    Cryer A
    Int J Biochem; 1981; 13(5):525-41. PubMed ID: 7016622
    [No Abstract]   [Full Text] [Related]  

  • 6. The roles of C-apolipoproteins in the metabolism of triglyceride-rich lipoproteins.
    Reckless JP; Stocks J; Holdsworth G
    Clin Sci (Lond); 1982 Feb; 62(2):125-9. PubMed ID: 7053911
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipoprotein lipase activator deficiency in very low density lipoproteins in rat nephrotic syndrome.
    Kashyap ML; de Mendoza SG; Campbell M; Chen CY; Lutmer RF; Glueck CJ
    Experientia; 1978 Aug; 34(8):1044-5. PubMed ID: 212287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.
    Haberbosch W; Poli A; Baggio G; Fellin R; Gnasso A; Augustin J
    Biochim Biophys Acta; 1984 Mar; 793(1):49-60. PubMed ID: 6704413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoproteins A and C; interaction with lipid monolayers.
    Jackson RL; Pattus F; de Haas G; Demel RA
    Ann N Y Acad Sci; 1980; 348():75-86. PubMed ID: 6772080
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of apolipoprotein C-II (apoC-II) on the lipolysis of very low density lipoproteins from apoC-II deficient patients.
    Matsuoka N; Shirai K; Johnson JD; Kashyap ML; Srivastava LS; Yamamura T; Yamamoto A; Saito Y; Kumagai A; Jackson RL
    Metabolism; 1981 Aug; 30(8):818-24. PubMed ID: 6894960
    [No Abstract]   [Full Text] [Related]  

  • 13. Redistribution of apolipoproteins C removed from human very low density lipoprotein during in vitro lipolysis by lipoprotein lipase.
    Glangeaud-Freudenthal MC; Burdin J; Ayrault-Jarrier M; Polonovski J
    Biochimie; 1981 Jun; 63(6):485-94. PubMed ID: 7260173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The competitive inhibition of C-II dependent lipoprotein lipase activity by heparin.
    Posner I
    Acta Cient Venez; 1983; 34(2):118-23. PubMed ID: 6544540
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the degradation of human very low density lipoproteins by human milk lipoprotein lipase.
    Wang CS; Weiser D; Alaupovic P; McConathy WJ
    Arch Biochem Biophys; 1982 Mar; 214(1):26-34. PubMed ID: 7082001
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipoprotein lipase: mechanism of action and role in lipoprotein metabolism.
    Quinn D; Shirai K; Jackson RL
    Prog Lipid Res; 1983; 22(1):35-78. PubMed ID: 6346343
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydrolysis of guinea pig nascent very low density lipoproteins catalyzed by lipoprotein lipase: activation by hjman apolipoprotein C-II.
    Fitzharris TJ; Quinn DM; Goh EH; Johnson JD; Kashyap ML; Srivastava LS; Jackson RL; Harmony JA
    J Lipid Res; 1981 Aug; 22(6):921-33. PubMed ID: 7276752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Existence of lipoprotein lipase in rat brain microvessels.
    Shirai K; Saito Y; Yoshida S; Matsuoka N
    Tohoku J Exp Med; 1986 Aug; 149(4):449-50. PubMed ID: 3775767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-bound lipoprotein lipase is catalytically active and can be stimulated by apolipoprotein CII.
    Bengtsson G; Olivecrona T
    FEBS Lett; 1981 Jun; 128(1):9-12. PubMed ID: 7274459
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of lipoprotein lipase with phospholipid vesicles. Role of apolipoprotein C-II and heparin.
    Shirai K; Matsuoka N; Jackson RL
    Biochim Biophys Acta; 1981 Sep; 665(3):504-10. PubMed ID: 6895327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.